Skip to content
PubMed This is a summary of 34 peer-reviewed journal articles Updated
Endocrinology · Type B Insulin Resistance Syndrome

Type B Insulin Resistance Syndrome (TBIRS) Patient Guide

At a Glance

Type B Insulin Resistance Syndrome (TBIRS) is a rare autoimmune disorder where the immune system attacks insulin receptors. Though severe, it is potentially curable using modern treatments like the NIH protocol, managed by endocrinology and rheumatology.

Welcome to the comprehensive resource guide for Type B Insulin Resistance Syndrome (TBIRS). Receiving a diagnosis of such a rare condition can be terrifying, especially when the treatments seem extreme. This guide is designed to empower you with the facts, the latest research, and the right questions to ask your care team.

TBIRS is an autoimmune condition—not standard diabetes—where your body’s immune system attacks its own insulin receptors. While historically it was considered very dangerous, modern medical protocols have transformed it into a potentially curable condition.

Explore the pages below to understand your diagnosis, treatment, and path to remission:

Common questions in this guide

What is Type B Insulin Resistance Syndrome (TBIRS)?
Type B Insulin Resistance Syndrome is a rare autoimmune condition where the body's immune system attacks its own insulin receptors. It is fundamentally different from standard diabetes and requires specialized autoimmune treatment.
Is Type B Insulin Resistance Syndrome curable?
Yes, while historically considered highly dangerous, modern medical protocols have transformed TBIRS into a potentially curable condition. Patients can achieve complete remission with the right treatment.
What is the NIH protocol for TBIRS?
The NIH protocol, sometimes called the Malek protocol, is a specific, intensive medical treatment designed to put TBIRS into remission. It works by stopping the immune system from attacking your insulin receptors.
Which doctors treat Type B Insulin Resistance Syndrome?
Because TBIRS involves both blood sugar dysregulation and an autoimmune attack, patients typically need a coordinated team. This usually includes an endocrinologist and a rheumatologist working closely together.
What are the blood sugar risks during TBIRS treatment?
Patients often experience extreme blood sugar swings, often described as a glycemic rollercoaster. During treatment, there is a very high risk of severe low blood sugar (hypoglycemia) as the insulin resistance begins to break.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Are you familiar with the NIH (Malek) protocol for treating Type B Insulin Resistance Syndrome?
  2. 2.Who will manage the coordination between my endocrinologist and my rheumatologist?
  3. 3.How will we manage the high risk of severe hypoglycemia when my insulin resistance begins to break?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

This guide provides educational information about Type B Insulin Resistance Syndrome (TBIRS) and the NIH protocol. It is not a substitute for professional medical advice, diagnosis, or treatment from your endocrinologist and rheumatologist.

Get notified when new evidence is published on Insulin-resistance syndrome type B.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.